Effects of inhibitors of arachidonic acid metabolism on Paf‐induced gastric mucosal necrosis and haemoconcentration
Open Access
- 1 October 1986
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 89 (2) , 415-422
- https://doi.org/10.1111/j.1476-5381.1986.tb10275.x
Abstract
The effects of several inhibitors of arachidonic acid metabolism on gastric necrosis, hypotension, haemoconcentration, leukopenia and plasma exudation induced by platelet‐activating factor (Paf) were studied in the rat. A 10 min intravenous infusion of Paf (100 ng kg−1 min−1) caused extensive gastric damage and a marked fall in systemic blood pressure which had not recovered to basal levels 30 min after the infusion had been terminated. Paf also caused significant haemoconcentration, plasma exudation and transient leukopenia. Pretreatment with dexamethasone (0.2 or 2 mg kg−1 s.c.) or prednisolone (20 mg kg−1 s.c.) two hours before Paf significantly reduced the gastric damage and accelerated the recovery of blood pressure after the Paf infusion. Likewise, BW755C (50 mg kg−1 p.o.) significantly reduced the gastric damage. Acute pretreatment with dexamethasone (2 mg kg−1 i.v.) 15 min before Paf, or with indomethacin (5 mg kg−1 s.c.), acetylsalicylic acid (10 mg kg−1 i.v.) or 1‐benzylimidazole (50 mg kg−1 s.c.) did not significantly affect the gastric damage induced by Paf. The Paf‐induced haemoconcentration and plasma exudation were significantly reduced by pretreatment with prednisolone (20 mg kg−1 s.c.) or BW755C (50 mg kg−1 p.o.), while Paf‐induced leukopenia was unaffected by either drug. These studies indicate that cyclo‐oxygenase products of arachidonic acid are unlikely to contribute significantly to the gastric damage or the prolonged hypotension induced by Paf. The ability of corticosteroids and BW755C to reduce the gastric damage, haemoconcentration and plasma exudation suggests that lipoxygenase products of arachidonic acid may contribute to these actions of Paf.This publication has 34 references indexed in Scilit:
- The effect of glucocorticoids on lyso-PAF formationin vitro andin vivoInflammation Research, 1986
- Hydrocortisone and ‘macrocortin’ inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytesLife Sciences, 1985
- Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophilsBiochemical and Biophysical Research Communications, 1984
- Stimulation of human neutrophil degranulation with 1-0-octadecyl-2-0-acetyl-sn-glyceryl-3-phosphorylcholine: Modulation by inhibitors of arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1982
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)Annals of the New York Academy of Sciences, 1981
- Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoidsNature, 1980
- Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytesEuropean Journal of Immunology, 1979
- Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generationNature, 1979
- Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophilsNature, 1974